The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma
Open Access
- 8 March 2025
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 25 (1) , 1-18
Abstract
The collagen β (1-O) glycosyltransferase 25 domain 1 (GLT25D1), a crucial collagen-modifying enzyme (CME), plays a pivotal role in multiple pathophysiological processes. However, its prognostic and biological roles in hepatocellular carcinoma (HCC) have not been reported. CME-related genes (CMEGs) were obtained from the Molecular Signatures Database (MSigDB), differentially expressed CMEGs (DECMEGs) and prognostic ones were identified. GLT25D1 expression was determined at the mRNA and protein levels in multiple datasets and in our HCC cohort. Its prognostic performance was evaluated and the immune microenvironment was investigated. The effects of GLT25D1 on tumorigenesis were further explored via in vitro and in vivo experiments. Four potential prognosis-associated DECMEGs, including GLT25D1, were identified. GLT25D1 was noticeably up-regulated in HCC tissues and significantly associated with advanced tumor grade and stage. Enrichment analysis revealed that GLT25D1 could participate in regulating immune responses and various carcinogenic processes. HCC patients with high GLT25D1 expression had decreased CD8+ T cells and increased M0 macrophages, leading to an immunosuppressive microenvironment. Our in vivo and in vitro experiments confirmed the increased GLT25D1 expression, and GLT25D1 knockdown impaired the HCC malignant phenotypes. Our results showed that GLT25D1 could be a carcinogenic indicator reflecting poor prognosis and might serve as a potential risk biomarker for HCC patients.Keywords
Funding Information
- the China Postdoctoral Science Foundation (2022MD713711)
- the Chongqing Natural Science Foundation Project-Postdoctoral Science Foundation Project (2022NSCQ-BHX0541)
- the National Natural Science Foundation (No. 82170816, No. 82170816)
This publication has 45 references indexed in Scilit:
- Collagen modifying enzyme P4HA1 is overexpressed and plays a role in lung adenocarcinomaTranslational Oncology, 2021
- Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithmInternational Immunopharmacology, 2021
- Down-regulation of GLT25D1 inhibited collagen secretion and involved in liver fibrogenesisGene, 2020
- Role of Glycosyltransferase 25 Domain 1 in Type I Collagen Glycosylation and Molecular PhenotypesBiochemistry, 2019
- MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4Biomedicine & Pharmacotherapy, 2018
- Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-δ-dependent neurocircuitryCell Death & Disease, 2017
- Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United StatesHepatology, 2017
- Cancer survival in China, 2003–2005: A population‐based studyInternational Journal of Cancer, 2014
- Management of HCCJournal of Hepatology, 2012
- Involvement of extracellular matrix constituents in breast cancerSeminars in Cancer Biology, 1995